The 2016 version of the CNS tumor classification introduced the classification of gliomas based on the coexistence of histologic and molecular features of the tumor, and incorporated molecular information such as IDH, 1p19q, among others, to grade and diagnose gliomas (4). This evidence concerns the gene IDH1 and central nervous system cancer.